IT8521944A0 - 1,4-diidropiridine-2-sostituite. - Google Patents

1,4-diidropiridine-2-sostituite.

Info

Publication number
IT8521944A0
IT8521944A0 IT8521944A IT2194485A IT8521944A0 IT 8521944 A0 IT8521944 A0 IT 8521944A0 IT 8521944 A IT8521944 A IT 8521944A IT 2194485 A IT2194485 A IT 2194485A IT 8521944 A0 IT8521944 A0 IT 8521944A0
Authority
IT
Italy
Prior art keywords
dihydropyridine
substituted
Prior art date
Application number
IT8521944A
Other languages
English (en)
Other versions
IT1201454B (it
Inventor
Carmelo A Gandolfi
Marco Frigerio
Silvano Spinelli
Ernesto Menta
Odoardo Tofanetti
Sergi Tognella
Original Assignee
Boehringer Biochemia Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Biochemia Srl filed Critical Boehringer Biochemia Srl
Priority to IT21944/85A priority Critical patent/IT1201454B/it
Publication of IT8521944A0 publication Critical patent/IT8521944A0/it
Priority to US06/889,377 priority patent/US4845113A/en
Priority to DE8686110517T priority patent/DE3687385D1/de
Priority to EP86110517A priority patent/EP0215250B1/en
Priority to AT86110517T priority patent/ATE84027T1/de
Priority to ZA865917A priority patent/ZA865917B/xx
Priority to JP61191162A priority patent/JPS6270359A/ja
Application granted granted Critical
Publication of IT1201454B publication Critical patent/IT1201454B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing alicyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Liquid Crystal Substances (AREA)
IT21944/85A 1985-08-19 1985-08-19 1,4-diidropiridine-2-sostituite IT1201454B (it)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IT21944/85A IT1201454B (it) 1985-08-19 1985-08-19 1,4-diidropiridine-2-sostituite
US06/889,377 US4845113A (en) 1985-08-19 1986-07-25 2-substituted -1,4-dihydropyridines and pharmaceutical compositions containing them
DE8686110517T DE3687385D1 (de) 1985-08-19 1986-07-30 2-substituierte-1,4-dihydropyridine, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
EP86110517A EP0215250B1 (en) 1985-08-19 1986-07-30 2-substituted-1,4-dihydropyridines, method for their preparation and pharmaceutical compositions containing them
AT86110517T ATE84027T1 (de) 1985-08-19 1986-07-30 2-substituierte-1,4-dihydropyridine, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ZA865917A ZA865917B (en) 1985-08-19 1986-08-06 2-substituted-1,4-dihydropyridines,method for their preparation and pharmaceutical compositions containing them
JP61191162A JPS6270359A (ja) 1985-08-19 1986-08-14 ２−置換−１，４−ジヒドロピリジン、その製法およびそれを含有する医薬組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21944/85A IT1201454B (it) 1985-08-19 1985-08-19 1,4-diidropiridine-2-sostituite

Publications (2)

Publication Number Publication Date
IT8521944A0 true IT8521944A0 (it) 1985-08-19
IT1201454B IT1201454B (it) 1989-02-02

Family

ID=11189184

Family Applications (1)

Application Number Title Priority Date Filing Date
IT21944/85A IT1201454B (it) 1985-08-19 1985-08-19 1,4-diidropiridine-2-sostituite

Country Status (7)

Country Link
US (1) US4845113A (it)
EP (1) EP0215250B1 (it)
JP (1) JPS6270359A (it)
AT (1) ATE84027T1 (it)
DE (1) DE3687385D1 (it)
IT (1) IT1201454B (it)
ZA (1) ZA865917B (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1204948B (it) * 1987-03-13 1989-03-10 Boheringer Biochemia Robin S P 2-tiometil-sostituite-piridine, metodo per la loro preparazione e composizioni farmaceutiche che le contengono.
IT1222591B (it) * 1987-09-04 1990-09-05 Boehringer Biochemia Srl 1,4-diidropiridine 2-alchil- ed alchenil-sostituite,metodo per la loro preparazione e composizione farmaceutiche che le contengono
ATE128623T1 (de) * 1988-08-02 1995-10-15 Nissan Chemical Ind Ltd Mittel zur verbesserung von arzneimitteleffekten für antitumormittel.
US5514693A (en) * 1988-12-15 1996-05-07 Farmitalia Carlo Erba S.R.L. Imidazolyl and pyridyl derivatives of phenyl substituted 1,4-dihydropyridines and process for their preparation
IL92646A0 (en) * 1988-12-15 1990-08-31 Erba Carlo Spa Imidazolyl and pyridyl derivatives of phenyl substituted 1,4-dihydropyridines,their preparation and pharmaceutical compositions containing them
GB9119983D0 (en) * 1991-09-19 1991-11-06 Erba Carlo Spa Dihydropyridine derivatives useful in antitumor therapy
US6887870B1 (en) * 1999-10-12 2005-05-03 Bristol-Myers Squibb Company Heterocyclic sodium/proton exchange inhibitors and method
RS53403A (sr) * 2000-12-29 2006-10-27 Pfizer Limited Postupak za dobijanje amlodipin maleata
CN105622493B (zh) * 2016-03-22 2020-10-16 江西师范大学 一种烯胺酮和醛串联反应合成全取代吡啶类化合物的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4307103A (en) * 1978-09-08 1981-12-22 Fujisawa Pharmaceutical Co., Ltd. Dihydropyridine derivative, processes for preparation thereof and pharmaceutical composition comprising the same
DE2949464A1 (de) * 1978-12-18 1980-06-26 Sandoz Ag Benzoxadiazole und benzothiadiazole, ihre herstellung und verwendung
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
DE3207982A1 (de) * 1982-03-05 1983-09-08 Bayer Ag, 5090 Leverkusen Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln
GB8306666D0 (en) * 1983-03-10 1983-04-13 Pfizer Ltd Therapeutic agents
US4690935A (en) * 1983-03-31 1987-09-01 Wayne State University Inhibition of tumor growth and metastasis with calcium channel blocker compounds
US4568677A (en) * 1983-07-23 1986-02-04 Pfizer Inc. 2-(4-Pyrimidone alkoxyalkyl) dihydropyridine anti-ischaemic and antihypertensive agents
DE3327650A1 (de) * 1983-07-30 1985-02-14 Gödecke AG, 1000 Berlin 1,6-naphthyridinon-derivate, verfahren zu deren herstellung und deren verwendung bei der bekaempfung von gefaesserkrankungen
JPS60120861A (ja) * 1983-12-02 1985-06-28 Otsuka Pharmaceut Co Ltd ジヒドロピリジン誘導体

Also Published As

Publication number Publication date
ZA865917B (en) 1987-04-29
JPS6270359A (ja) 1987-03-31
EP0215250B1 (en) 1992-12-30
DE3687385D1 (de) 1993-02-11
IT1201454B (it) 1989-02-02
ATE84027T1 (de) 1993-01-15
EP0215250A1 (en) 1987-03-25
US4845113A (en) 1989-07-04

Similar Documents

Publication Publication Date Title
FI861210A0 (fi) N,n'-dialkylguanidinodipeptider.
FI860860A0 (fi) Stabiliserat, flytande tvaettmedel foer textiler.
FI864237L (fi) Foerfarande foer framstaellning av 1,6-diklor-1,6-dideoxi- -d-fruktofuranosyl-4-klor-4-deoxi- -galaktopyranosider.
DE3669876D1 (de) 3,4-dihydrobenzopyranderivate.
FI864271A7 (fi) Substituerade p,p'-metylen-bis -aniliner.
FI854870A0 (fi) Oljekyld, flerdelad saenkkolv foer slagkolvsfoerbraenningsmotor.
FI853553A0 (fi) Kontinuerligt arbetande, tryckvalsfoersedd paorullningsanordning.
FI861416L (fi) Foerfarande foer framstaellning av farmakologiskt aktiva 2,3,4,5-tetrahydro-lh-3-benzazepiner.
FI861009A0 (fi) Hydroelastisk uppbaerningsanordning foer mobila, sjaelvlyftande borrplattformar.
FI86060B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,4-naftalendioner.
FI862343A7 (fi) Foerfarande foer framstaellning av terapeutiskt verkande 1,4-dihydropyridinfoereningar.
FI860247L (fi) Foerfarande foer framstaellning av 4,4-dialkyl-2-azetidinoner.
FI861951A7 (fi) 1,3-oxatianderivat.
ATE68471T1 (de) Gem-dihalo-1,8-diamino-4-aza-oktane.
FI855170A0 (fi) Sorterare, saerskilt vertikalsikt.
FI863300A0 (fi) 7-oxo-4-tia-1-azabicyclo/3,2,0/ hept-2-enderivat.
FI861950A0 (fi) 1,3-dioxan-etrar.
DE3684900D1 (de) 2,2'-bi-1h-imidazole.
FI861275A7 (fi) Foerfarande foer framstaellning av farmakologiskt aktiva 16,17-asetalsubstituerade androstan-17 -karboxylsyraestrar.
FI855182A0 (fi) Foerfarande foer framstaellning av 1,3 -disubstituerade tetrahydropyridiner.
FI865244A7 (fi) Foerfarande foer framstaellning av optiskt aktiva 2-klor-12-(3-dimetylamino-2-metylpropyl)-12h-dibenzo-/d,g//1,3,6/ dioxazociner.
FI860454A7 (fi) Daeckregummeringsfoerfarande, varvid staolgoerdelskikt foernyas.
FI865158A0 (fi) 1-h-pyrido/3,2//1,4/-tiaziner.
IT8620495A0 (it) 2,4-dicloro-5-nitro-tiazolo.
FI863082A7 (fi) Foerfarande foer framstaellning av 5,6-dialkoxiantanilsyror.